...
首页> 外文期刊>Carcinogenesis >Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells
【24h】

Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells

机译:异水飞蓟宾B和异水飞蓟宾A抑制人前列腺癌LNCaP和22Rv1细胞的生长,诱导G 1 阻滞并引起细胞凋亡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Silymarin and, one of its constituents, silibinin exert strong efficacy against prostate cancer (PCA); however, anticancer efficacy and associated mechanisms of other components of silymarin, which is a mixture of flavonolignans, are largely unknown. Here we have assessed the anticancer efficacy of two pure compounds isosilybin B and isosilybin A, isolated from silymarin, in human prostate carcinoma LNCaP and 22Rv1 cells. Isosilybin B and isosilybin A treatment resulted in growth inhibition and cell death together with a strong G1 arrest and apoptosis in both the cell lines. In the studies examining changes in cell cycle and apoptosis regulators, isosilybin B and isosilybin A resulted in a decrease in the levels of both cyclins (D1, D3, E and A) and cyclin-dependent kinases (Cdk2, Cdk4 and cell division cycle 25A), but caused an increase in p21, p27 and p53 levels, except in 22Rv1 cells where isosilybin B caused a decrease in p21 protein level. Isosilybin B- and isosilybin A-induced apoptosis was accompanied with an increase in the cleavage of poly (ADP-ribose) polymerase, caspase-9 and caspase-3 and a decrease in survivin levels. Compared with LNCaP and 22Rv1 cells, the antiproliferative and cytotoxic potentials of isosilybin B and isosilybin A were of much lesser magnitude in non-neoplastic human prostate epithelial PWR-1E cells suggesting the transformation-selective effect of these compounds. Together, this study for the first time identified that isosilybin B and isosilybin A, two diastereoisomers isolated from silymarin, have anti-PCA activity that is mediated via cell cycle arrest and apoptosis induction.
机译:水飞蓟素及其成分之一水飞蓟宾对前列腺癌(PCA)具有强大的功效;然而,水飞蓟素(黄酮木聚糖的混合物)的其他成分的抗癌功效和相关机制在很大程度上尚不清楚。在这里,我们评估了从水飞蓟素中分离得到的两种纯化合物异水飞蓟宾B和异水飞蓟宾A在人前列腺癌LNCaP和22Rv1细胞中的抗癌作用。异水飞蓟宾B和异水飞蓟宾A处理导致生长抑制和细胞死亡,以及两个细胞系中强烈的G 1 阻滞和凋亡。在研究细胞周期和凋亡调节剂变化的研究中,异水飞蓟宾B和异水飞蓟宾A导致细胞周期蛋白(D1,D3,E和A)和细胞周期蛋白依赖性激酶(Cdk2,Cdk4和细胞分裂周期25A)的水平降低),但会导致p21,p27和p53的水平增加,但在22Rv1细胞中,异麦冬蛋白B导致p21蛋白质的水平下降。异水飞蓟宾B和异水飞蓟宾A诱导的细胞凋亡伴随着多聚(ADP-核糖)聚合酶,caspase-9和caspase-3的切割增加以及生存素水平降低。与LNCaP和22Rv1细胞相比,异水飞蓟宾B和异水飞蓟宾A在非肿瘤性人前列腺上皮PWR-1E细胞中的抗增殖和细胞毒性潜力要小得多,表明这些化合物的转化选择性作用。总之,这项研究首次确定了从水飞蓟素分离出的两种非对映异构体异水飞蓟宾B和异水飞蓟宾A具有抗PCA活性,该活性是通过细胞周期停滞和凋亡诱导介导的。

著录项

  • 来源
    《Carcinogenesis》 |2007年第7期|1533-1542|共10页
  • 作者单位

    Department of Pharmaceutical Sciences School of Pharmacy University of Colorado Health Sciences Center Denver CO USA;

    Natural Products Laboratory Center for Organic and Medicinal Chemistry Research Triangle Institute Research Triangle Park NC USA;

    University of Colorado Cancer Center University of Colorado Health Sciences Center Denver CO USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号